- New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus.
- Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, intensive care unit (ICU) admission, and death.
- Vaccination reduces the risks of severe disease and death even with the VOCs.
- However, even with increased vaccination, control measures are needed to reduce the spread of the VOCs.
A Canadian study has found a link between the new variants of SARS-CoV-2, particularly the Delta variant, and an increased risk of severe disease and death.
The retrospective study, by the University of Toronto and appearing in the Canadian Medical Association Journal (CMAJ), looked at 212,326 cases in Ontario from February 7 to June 27, 2021. The study authors compared the risks of hospitalization, ICU admission, and death from the VOCs with those risks from non-VOC SARS-CoV-2 strains.
The researchers screened the cases for Alpha, Beta, Gamma, and Delta VOCs. Non-VOC infections made up 22.4% of the cases. More than three-quarters of the cases were Alpha, Beta, or Gamma, while 2.8% were probably Delta.
Alpha, Beta, and Gamma variants have a mutation that increasesTrusted Source transmission, while Delta has a mutation that increases its ability to replicate.
The authors note that before May 2021, there was no routine screening for the Delta variant, so it is likely that the numbers underestimate the prevalence of this variant.
Increased risk from the Delta variant
The present study found that all VOCs increased people’s risk of hospitalization, ICU admission, and death due to COVID-19.
However, the highest risks were from the Delta variant. In the Delta cases, there was a 108% increase in the risk of hospitalization, a 235% increased risk of ICU admission, and a 133% higher risk of death, compared with the original variant.
These effects were present even when the researchers adjusted the data for factors such as age, sex, vaccination status, and comorbidities.
Prof. William Schaffner, infectious diseases specialist at the Vanderbilt University Medical Center in Nashville, TN, commented:
“This important study from Canada reinforces the serious impact the Delta variant is having. It is well recognized that Delta is more contagious than other virus variants. This new study convincingly reinforces the finding that it also causes more severe disease.”
The Delta variant is now the dominant variant in the European Union, the United Kingdom, and the United States.
The findings of the present study corroborate those of the studies in EnglandTrusted Source, ScotlandTrusted Source, and Singapore that have also shown increased risks from the Delta variant.
Speaking to Medical News Today, Dr. Christopher Coleman, assistant professor of infection immunology at the University of Nottingham in the U.K., highlighted the international relevance of the study.
He said, “Although this [Canadian] study has some limitations, as acknowledged by the authors, this is exactly the kind of study that helps ‘build a picture’ by showing that similar observations can be observed in a lot of different circumstances.”
“It is not something unique about the U.K. that means the Delta variant is associated with more dangerous infections only here,” he added.
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
Breakthrough in Antimicrobial Technology with Cinnamon-Based Nanokiller
The need for innovative antimicrobial agents has become increasingly urgent due to the rise of antibiotic-resistant pathogens and the persistent threat of infections acquired during hospital stays. Traditional antibiotics and antiseptics are often ineffective [...]
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]